title: Update on Ophthalmic Oncology 2013: Retinoblastoma and Uveal Melanoma.
abstract: OBJECTIVE
  The aim of this study was to discuss the clinical and translational content of the literature as well as advancement in our knowledge pertaining to retinoblastoma and uveal melanoma that were published from January to December 2013.
  
  
  METHODS
  This study is a literature review.
  
  
  METHODS
  The search terms retinoblastoma and uveal melanoma were used in a MEDLINE literature search. Abstracts were studied, and the most relevant articles were selected for inclusion and further in-depth review.
  
  
  RESULTS
  In retinoblastoma, fewer eyes are lost because of the expanded use of ophthalmic artery chemosurgery and intravitreal melphalan, and the past year marks a deepening in our understanding of these modalities. Knowledge on the genetic underpinnings of uveal melanoma has broadened to include genes associated with a favorable prognosis. This is accompanied by promising results in the treatment of metastatic uveal melanoma.
  
  
  CONCLUSIONS
  This past year, there were important advancements in our knowledge of retinoblastoma and uveal melanoma.
authors.affiliation: From the Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Jasmine H
authors.initials: JH
authors.lastname: Francis
authors.forename: David H
authors.initials: DH
authors.lastname: Abramson